Home Pharmaceuticals In the crowded cardio space, it’s David vs. Goliath for small biotechs

In the crowded cardio space, it’s David vs. Goliath for small biotechs

by Newsroom


This audio is auto-generated. Please let us know if you have feedback.

The cardiovascular space is filled with some of the biggest pharma and biotech players in the world. Not only did the weight loss phenomenon Wegovy score a cardiovascular indication last year, but giants like Merck & Co. are making moves, too. 

Merck anticipates…



Source link

You may also like

About Us

Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Health Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC